WINDLAS BIOTECH
|
WINDLAS BIOTECH Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 31.49 | 29.10 | 27.98 | 20.37 | 17.48 |
| CEPS(Rs) | 46.05 | 42.45 | 34.44 | 26.28 | 23.05 |
| DPS(Rs) | 6.30 | 5.80 | 5.50 | 4.00 | 3.50 |
| Book NAV/Share(Rs) | 265.88 | 238.80 | 213.99 | 190.89 | 180.31 |
| Tax Rate(%) | 23.59 | 23.53 | 24.52 | 25.27 | 16.41 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.59 | 12.38 | 12.39 | 11.74 | 11.25 |
| EBIT Margin(%) | 10.15 | 11.07 | 12.39 | 11.27 | 10.08 |
| Pre Tax Margin(%) | 9.62 | 10.50 | 12.22 | 11.12 | 9.78 |
| PAT Margin (%) | 7.35 | 8.03 | 9.22 | 8.31 | 8.17 |
| Cash Profit Margin (%) | 10.75 | 11.71 | 11.35 | 10.72 | 10.78 |
| Performance Ratios | |||||
| ROA(%) | 7.97 | 8.80 | 10.10 | 8.39 | 9.70 |
| ROE(%) | 12.52 | 12.90 | 13.78 | 10.76 | 12.87 |
| ROCE(%) | 16.06 | 17.12 | 18.34 | 14.39 | 14.88 |
| Asset Turnover(x) | 1.08 | 1.10 | 1.09 | 1.01 | 1.19 |
| Sales/Fixed Asset(x) | 2.54 | 2.45 | 2.69 | 2.87 | 2.68 |
| Working Capital/Sales(x) | 2.96 | 2.75 | 2.43 | 2.21 | 1.62 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.39 | 0.41 | 0.37 | 0.35 | 0.37 |
| Receivable days | 79.59 | 72.81 | 73.22 | 80.97 | 74.49 |
| Inventory Days | 28.91 | 34.48 | 39.61 | 47.47 | 39.24 |
| Payable days | 140.29 | 124.42 | 106.89 | 92.18 | 64.78 |
| Valuation Parameters | |||||
| PER(x) | 23.43 | 35.78 | 18.31 | 11.06 | 12.02 |
| PCE(x) | 16.02 | 24.53 | 14.88 | 8.57 | 9.11 |
| Price/Book(x) | 2.77 | 4.36 | 2.39 | 1.18 | 1.17 |
| Yield(%) | 0.85 | 0.56 | 1.07 | 1.78 | 1.67 |
| EV/Net Sales(x) | 1.75 | 2.89 | 1.64 | 0.87 | 0.75 |
| EV/Core EBITDA(x) | 12.93 | 19.56 | 11.29 | 6.36 | 5.92 |
| EV/EBIT(x) | 17.26 | 26.07 | 13.23 | 7.72 | 7.45 |
| EV/CE(x) | 2.60 | 4.12 | 2.30 | 1.11 | 0.72 |
| M Cap / Sales | 1.72 | 2.87 | 1.69 | 0.92 | 0.98 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 18.98 | 20.43 | 22.97 | 10.12 | 8.96 |
| Core EBITDA Growth(%) | 9.29 | 22.35 | 30.56 | 18.71 | 2.33 |
| EBIT Growth(%) | 9.11 | 7.60 | 35.22 | 23.08 | 104.00 |
| PAT Growth(%) | 8.95 | 4.82 | 36.51 | 11.91 | 144.63 |
| EPS Growth(%) | 8.20 | 4.01 | 37.35 | 16.55 | -29.23 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.05 | 0.05 | - | - | 0.02 |
| Current Ratio(x) | 1.95 | 2.11 | 2.51 | 2.92 | 4.06 |
| Quick Ratio(x) | 1.76 | 1.78 | 2.15 | 2.30 | 3.44 |
| Interest Cover(x) | 19.02 | 19.20 | 70.77 | 73.38 | 33.16 |
| Total Debt/Mcap(x) | 0.02 | 0.01 | - | - | 0.01 |
Compare Financial Ratios of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,709.4 Cr | -3.4% | 1.4% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -3.4% |
1.4% |
-8.5% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses
